Literature DB >> 20215367

Epidemiological characteristics and diagnostic approach in patients admitted to the emergency room for transient loss of consciousness: Group for Syncope Study in the Emergency Room (GESINUR) study.

Gonzalo Baron-Esquivias1, Jesús Martínez-Alday, Alfonso Martín, Angel Moya, Roberto García-Civera, M Paz López-Chicharro, María Martín-Mendez, Carmen del Arco, Pedro Laguna.   

Abstract

AIMS: To assess the clinical presentation and acute management of patients with transient loss of consciousness (T-LOC) in the emergency department (ED). METHODS AND
RESULTS: A multi-centre prospective observational study was carried out in 19 Spanish hospitals over 1 month. The patients included were > or =14 years old and were admitted to the ED because of an episode of T-LOC. Questionnaires and corresponding electrocardiograms (ECGs) were reviewed by a Steering Committee (SC) to unify diagnostic criteria, evaluate adherence to guidelines, and diagnose correctly the ECGs. We included 1419 patients (prevalence, 1.14%). ECG was performed in 1335 patients (94%) in the ED: 498 (37.3%) ECGs were classified as abnormal. The positive diagnostic yield ranged from 0% for the chest X-ray to 12% for the orthostatic test. In the ED, 1217 (86%) patients received a final diagnosis of syncope, whereas the remaining 202 (14%) were diagnosed of non-syncopal transient loss of consciousness (NST-LOC). After final review by the SC, 1080 patients (76%) were diagnosed of syncope, whereas 339 (24%) were diagnosed of NST-LOC (P < 0.001). Syncope was diagnosed correctly in 84% of patients. Only 25% of patients with T-LOC were admitted to hospitals.
CONCLUSION: Adherence to clinical guidelines for syncope management was low; many diagnostic tests were performed with low diagnostic yield. Important differences were observed between syncope diagnoses at the ED and by SC decision.

Entities:  

Mesh:

Year:  2010        PMID: 20215367     DOI: 10.1093/europace/euq018

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  11 in total

1.  Application Of The American College Of Emergency Physicians (ACEP) Recommendations And a Risk Stratification Score (OESIL) For Patients With Syncope Admitted From The Emergency Department.

Authors:  Adrian Baranchuk; William McIntyre; William Harper; Carlos A Morillo
Journal:  Indian Pacing Electrophysiol J       Date:  2011-10-02

2.  2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.

Authors:  Jonathan S Steinberg; Niraj Varma; Iwona Cygankiewicz; Peter Aziz; Paweł Balsam; Adrian Baranchuk; Daniel J Cantillon; Polychronis Dilaveris; Sergio J Dubner; Nabil El-Sherif; Jaroslaw Krol; Malgorzata Kurpesa; Maria Teresa La Rovere; Suave S Lobodzinski; Emanuela T Locati; Suneet Mittal; Brian Olshansky; Ewa Piotrowicz; Leslie Saxon; Peter H Stone; Larisa Tereshchenko; Mintu P Turakhia; Gioia Turitto; Neil J Wimmer; Richard L Verrier; Wojciech Zareba; Ryszard Piotrowicz
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05       Impact factor: 1.468

3.  Patients with syncope in a German emergency department: description of patients and processes.

Authors:  Sebastian Güldner; Viktoria Langada; Steffen Popp; Hans Jürgen Heppner; Harald Mang; Michael Christ
Journal:  Dtsch Arztebl Int       Date:  2012-01-27       Impact factor: 5.594

4.  Randomized clinical trial of an emergency department observation syncope protocol versus routine inpatient admission.

Authors:  Benjamin C Sun; Heather McCreath; Li-Jung Liang; Stephen Bohan; Christopher Baugh; Luna Ragsdale; Sean O Henderson; Carol Clark; Aveh Bastani; Emmett Keeler; Ruopeng An; Carol M Mangione
Journal:  Ann Emerg Med       Date:  2013-11-13       Impact factor: 5.721

5.  Transient loss of consciousness assessment in a University Hospital: From diagnosis to prognosis.

Authors:  Mariana Silva; Ana Godinho; João Freitas
Journal:  Porto Biomed J       Date:  2016-08-25

6.  Machine learning as a diagnostic decision aid for patients with transient loss of consciousness.

Authors:  Alistair Wardrope; Jenny Jamnadas-Khoda; Mark Broadhurst; Richard A Grünewald; Timothy J Heaton; Stephen J Howell; Matthias Koepp; Steve W Parry; Sanjay Sisodiya; Matthew C Walker; Markus Reuber
Journal:  Neurol Clin Pract       Date:  2020-04

7.  Unexplained Syncope and Diagnostic Yield of Tests in Syncope According to the ICD-10 Discharge Diagnosis.

Authors:  Martin Huth Ruwald; Morten Lock Hansen; Morten Lamberts; Michael Vinther; Christian Torp-Pedersen; Jim Hansen; Gunnar Hilmar Gislason
Journal:  J Clin Med Res       Date:  2013-10-12

8.  Structured syncope care pathways based on lean six sigma methodology optimises resource use with shorter time to diagnosis and increased diagnostic yield.

Authors:  Leon Martens; Grahame Goode; Johan F H Wold; Lionel Beck; Georgina Martin; Christian Perings; Pelle Stolt; Lucas Baggerman
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

9.  Prohormones in the Early Diagnosis of Cardiac Syncope.

Authors:  Patrick Badertscher; Thomas Nestelberger; Jeanne du Fay de Lavallaz; Martin Than; Beata Morawiec; Damian Kawecki; Òscar Miró; Beatriz López; F Javier Martin-Sanchez; José Bustamante; Nicolas Geigy; Michael Christ; Salvatore Di Somma; W Frank Peacock; Louise Cullen; François Sarasin; Dayana Flores; Michael Tschuck; Jasper Boeddinghaus; Raphael Twerenbold; Karin Wildi; Zaid Sabti; Christian Puelacher; Maria Rubini Giménez; Nikola Kozhuharov; Samyut Shrestha; Ivo Strebel; Katharina Rentsch; Dagmar I Keller; Imke Poepping; Andreas Buser; Wanda Kloos; Jens Lohrmann; Michael Kuehne; Stefan Osswald; Tobias Reichlin; Christian Mueller
Journal:  J Am Heart Assoc       Date:  2017-12-14       Impact factor: 5.501

10.  Financial impact of adopting implantable loop recorder diagnostic for unexplained syncope compared with conventional diagnostic pathway in Portugal.

Authors:  Rui Providência; Rui Candeias; Carlos Morais; Hipólito Reis; Luís Elvas; Vitor Sanfins; Sara Farinha; Simon Eggington; Stelios Tsintzos
Journal:  BMC Cardiovasc Disord       Date:  2014-05-06       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.